Cardiac sarcoidosis: an overview of management for the patient requiring oral and maxillofacial surgery.
OBJECTIVE
The study goal was to present a current definition of sarcoidosis and an overview of cardiac involvement and implications in perioperative management of cardiac sarcoidosis.


METHODS
Materials included a retrospective review of 4 patients with cardiac sarcoidosis who underwent minor oral surgery. Laboratory data, medical data, and data obtained through monitoring the patient's general condition related to the surgery were critically analyzed.


RESULTS
Preoperative understanding of cardiac pathophysiology, evaluation of the patient's general condition, laboratory data, medical records, and physician correspondence were important, as was precise treatment planning against cardiac emergencies that could occur in surgical treatments. It was essential to monitor vital signs, any electrocardiographic changes, blood pressure, and heart rate, starting from the pretreatment period and continuing through the oral and maxillofacial surgery into the post-treatment period. Glucocorticosteroid coverage and prevention of endocarditis were also considered during oral and maxillofacial surgery planning.


CONCLUSIONS
Critical issues were identified in the performance of oral and maxillofacial surgery for patients with cardiac sarcoidosis.
Yoshimura
Yasuro
Y
Department of Oral and Maxillofacial Surgery, Shimane Medical University, School of Medicine, Shimane, Japan. omfs1@shimane-med.ac.jp
Matsuda
Shuji
S
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001145:Arrhythmias, Cardiac / Q000209:etiology; D009202:Cardiomyopathies / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D017742:Dental Care for Chronically Ill; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008875:Middle Aged; D016343:Monitoring, Intraoperative; D019647:Oral Surgical Procedures; D012507:Sarcoidosis / Q000175:diagnosis / Q000188:drug therapy; D013256:Steroids
D000893:Anti-Inflammatory Agents; D013256:Steroids